Your browser doesn't support javascript.
loading
Serologic studies of MS patients, controls, and patients with other neurologic diseases: antibodies to HTLV-I, II, III.
Madden, D L; Mundon, F K; Tzan, N R; Fuccillo, D A; Dalakas, M C; Calabrese, V; Elizan, T S; Sever, J L.
  • Madden DL; National Institute of Neurological and Communicative Disorders and Stroke, MD 20892.
Neurology ; 38(1): 81-4, 1988 Jan.
Article en En | MEDLINE | ID: mdl-2827054
ABSTRACT
We have studied the frequency of human retrovirus antibody (HTLV-I, II, III) in the serum and CSF of patients with MS, matched controls, and patients with optic neuritis, idiopathic and postencephalitic Parkinson's disease, neuropathies, polymyositis, ALS, and postpoliomyelitis. Except for the postpoliomyelitis samples, all samples were collected prior to 1980. Contrary to a previous published report, no significant levels of antibody to HTLV-I, II, or III were found in the MS patients or controls. No retrovirus antibody was detected in patients with the other neurologic diseases.
Asunto(s)
Search on Google
Banco de datos: MEDLINE Asunto principal: VIH / Deltaretrovirus / Anticuerpos Antivirales / Esclerosis Múltiple / Enfermedades del Sistema Nervioso Límite: Humans Idioma: En Año: 1988 Tipo del documento: Article
Search on Google
Banco de datos: MEDLINE Asunto principal: VIH / Deltaretrovirus / Anticuerpos Antivirales / Esclerosis Múltiple / Enfermedades del Sistema Nervioso Límite: Humans Idioma: En Año: 1988 Tipo del documento: Article